Select Medical completed the divestiture of Concentra, fundamentally reshaping the company into a pure-play hospital and rehabilitation services provider.
The removal of all Concentra references and updated segment descriptions indicate Select Medical has exited its occupational health business, likely through a sale that should have generated significant proceeds. This strategic refocusing on core hospital operations represents a major business transformation that will change the company's growth profile, margins, and competitive positioning going forward.
The financial results show a mixed picture following the Concentra divestiture, with operating income surging 25.3% to $336.2M suggesting improved operational efficiency in the remaining hospital business, but net income declining 31.7% to $146.2M likely due to transaction costs and lost Concentra earnings. The dramatic 75% reduction in dividends paid and 56% drop in cash position indicates management is conserving capital post-transaction, while the 33% decline in operating cash flow reflects the loss of Concentra's cash generation, creating a leaner but potentially more focused operation.
Dividends cut 75.4% — significant signal of cash flow stress or capital reallocation priorities.
Cash declined 55.6% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Operating cash flow fell 33.1% — earnings quality concerns; investigate working capital changes and non-cash items.
Net income declined 31.7% — review whether driven by operations, interest costs, or non-recurring items.
Operating income improving — cost discipline or growing revenue base absorbing fixed costs.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →